Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
about
The law (and politics) of safe injection facilities in the United StatesSummary of findings from the evaluation of a pilot medically supervised safer injecting facilityCorrelates of public support toward federal funding for harm reduction strategies.Amazing grace: Vancouver's supervised injection facility granted six-month lease on life.Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort studyMitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facilityAcceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian CityAcceptability of a safer injection facility among injection drug users in San Francisco.'Safer environment interventions': a qualitative synthesis of the experiences and perceptions of people who inject drugs.An appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite.Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.Policy makers ignoring science and scientists ignoring policy: the medical ethical challenges of heroin treatment.Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatmentCanada's highest court unchains injection drug users; implications for harm reduction as standard of healthcareAdvancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitalsThe North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage.The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugsIncidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.The context of illicit drug overdose deaths in British Columbia, 2006The Complexities of Accessing Care and Treatment: Understanding Alcohol Use by Aboriginal Persons Living with HIV and AIDS.Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.Injection drug use cessation and use of North America's first medically supervised safer injecting facility.The willingness of people who inject drugs in Boston to use a supervised injection facility.IDU perspectives on the design and operation of North America's first medically supervised injection facility.Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.Identifying heterogeneity among injection drug users: a cluster analysis approach.Recent incarceration and use of a supervised injection facility in Vancouver, CanadaCircumstances of first injection among illicit drug users accessing a medically supervised safer injection facilityAn integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation
P2860
Q24657290-6E33F094-4AA9-438B-8D3D-FC5CABFC8689Q24673390-2B0A598D-1E39-42F3-A0DD-DC0F7AFA9168Q30279094-FC68C773-1EDB-40B0-8BF9-343E86391187Q30481221-FCA8CBD1-32F1-40B7-B96D-14725EAE7CFCQ33391591-5CA920D9-B03C-4E17-85A9-5AA8828D8034Q33717043-79C5A205-C3D8-42C7-A71C-ECB47777C701Q33910606-F62523C1-A8EB-4401-95E5-4233F7DAF26CQ33912772-595EA1A5-59F8-4FD3-A597-EA96FD3DB67EQ34046338-2B7ACC86-936A-4E00-957C-F57F8ED9189FQ34221599-669D8A43-0DD5-4D54-B378-E178A8F633F9Q34251466-D81D6AA7-B232-43ED-A54C-A4CC260FA40CQ35012581-A8985D9D-A4B8-4F9E-AAB2-777FE594CC4EQ35127554-12D66CE7-DF98-4481-BD00-E828439B284EQ35578532-1C5BAD14-D1B7-4B10-BE0B-CD07A855A7BDQ36380319-19A957C7-7FF0-45F7-B680-C6A8A43E9619Q36711924-0F8375FA-FFA3-4A5B-AAC3-EBD046DA9088Q36985312-78FC5867-A1B3-49F1-B381-6D672F9CC0D1Q37009231-93CAD0EC-B2CB-4149-9A52-0F5457B8A251Q37020250-74E6881F-2F64-4568-9083-FE2ECF105421Q37032437-8B3AD3BB-2B60-441A-B613-898FD1DCD25EQ37062964-B3E94F13-0456-44C1-A8DD-C63DD1A942CBQ37114061-5ADD4194-E857-4A85-BFD1-42A356A384C8Q37221984-7DD8D5E3-14BB-4225-A1F1-AD9F8F5E0A83Q37418488-2906B0E1-28B5-476A-A31F-064FB652AE4BQ37655493-3DB9C558-C405-42E9-9356-EAC821423E5FQ41193164-B2EB18C3-E604-4789-B279-6E87E8B862E3Q41502073-2F136B4A-E236-4F3A-A4C5-DB06B8160AC1Q41949791-27A725B6-4B1E-48B8-81AC-1EB3000A9E46Q42676669-0A081E00-174B-426E-A7B5-5E485E1A0F71Q45130692-B0ED13BD-E6B3-43DA-AF1D-D1011634FB4CQ47316128-53AFD59A-5B2F-49D0-AE8B-F2E8ACE3B627Q51698391-34D6E60B-9066-402A-9713-20C4E5CABE11Q57690307-531E7C09-8BEB-4833-B8FE-94CA2078EEC0Q57690463-0C63EF9B-23F7-4E6A-A8E9-95D570DDCD89Q58126719-2D96D655-46C0-447F-9328-F0408AA87C5A
P2860
Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Attendance, drug use patterns, ...... supervised injection facility.
@ast
Attendance, drug use patterns, ...... supervised injection facility.
@en
type
label
Attendance, drug use patterns, ...... supervised injection facility.
@ast
Attendance, drug use patterns, ...... supervised injection facility.
@en
prefLabel
Attendance, drug use patterns, ...... supervised injection facility.
@ast
Attendance, drug use patterns, ...... supervised injection facility.
@en
P2093
P1476
Attendance, drug use patterns, ...... supervised injection facility.
@en
P2093
Evelyn King
Julio G Montaner
Mark W Tyndall
Ruth Zhang
P304
P356
10.1016/J.DRUGALCDEP.2005.11.011
P577
2005-12-13T00:00:00Z